Gardner P - Search Results

1

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.

Wagner JA, Moran ML, Messner AH, Daifuku R, Conrad CK, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P. Wagner JA, et al. Among authors: gardner p. Hum Gene Ther. 1998 Apr 10;9(6):889-909. doi: 10.1089/hum.1998.9.6-889. Hum Gene Ther. 1998. PMID: 9581911 Clinical Trial. No abstract available.

2

Molecular strategies for therapy of cystic fibrosis.

Wagner JA, Chao AC, Gardner P. Wagner JA, et al. Among authors: gardner p. Annu Rev Pharmacol Toxicol. 1995;35:257-76. doi: 10.1146/annurev.pa.35.040195.001353. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598494 Review.

3

Toward cystic fibrosis gene therapy.

Wagner JA, Gardner P. Wagner JA, et al. Among authors: gardner p. Annu Rev Med. 1997;48:203-16. doi: 10.1146/annurev.med.48.1.203. Annu Rev Med. 1997. PMID: 9046956 Review.

4

Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies.

Wagner JA, Nepomuceno IB, Shah N, Messner AH, Moran ML, Norbash AM, Moss RB, Wine JJ, Gardner P. Wagner JA, et al. Among authors: gardner p. J Gene Med. 1999 Jan-Feb;1(1):13-21. doi: 10.1002/(sici)1521-2254(199901/02)1:1<13::aid-jgm6>3.3.co;2-7. J Gene Med. 1999. PMID: 10738581 Clinical Trial.

5

Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

Wagner JA, Messner AH, Moran ML, Daifuku R, Kouyama K, Desch JK, Manley S, Norbash AM, Conrad CK, Friborg S, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P. Wagner JA, et al. Among authors: gardner p. Laryngoscope. 1999 Feb;109(2 Pt 1):266-74. doi: 10.1097/00005537-199902000-00017. Laryngoscope. 1999. PMID: 10890777 Clinical Trial.

6

Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).

Moss RB, Bocian RC, Hsu YP, Dong YJ, Kemna M, Wei T, Gardner P. Moss RB, et al. Among authors: gardner p. Clin Exp Immunol. 1996 Nov;106(2):374-88. doi: 10.1046/j.1365-2249.1996.d01-826.x. Clin Exp Immunol. 1996. PMID: 8918588 Free PMC article.

7

Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus.

Wagner JA, Reynolds T, Moran ML, Moss RB, Wine JJ, Flotte TR, Gardner P. Wagner JA, et al. Among authors: gardner p. Lancet. 1998 Jun 6;351(9117):1702-3. doi: 10.1016/S0140-6736(05)77740-0. Lancet. 1998. PMID: 9734891 Free article. No abstract available.

8

Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase.

Chao AC, de Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P. Chao AC, et al. Among authors: gardner p. EMBO J. 1994 Mar 1;13(5):1065-72. doi: 10.1002/j.1460-2075.1994.tb06355.x. EMBO J. 1994. PMID: 7510634 Free PMC article.

9

Activation of CFTR chloride current by nitric oxide in human T lymphocytes.

Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Dong YJ, et al. Among authors: gardner p. EMBO J. 1995 Jun 15;14(12):2700-7. doi: 10.1002/j.1460-2075.1995.tb07270.x. EMBO J. 1995. PMID: 7540975 Free PMC article.

10

Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents.

Wagner JA, McDonald TV, Nghiem PT, Lowe AW, Schulman H, Gruenert DC, Stryer L, Gardner P. Wagner JA, et al. Among authors: gardner p. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6785-9. doi: 10.1073/pnas.89.15.6785. Proc Natl Acad Sci U S A. 1992. PMID: 1379720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,379 results

Search Page

Filters